사이버 연수원

고신대학교복음병원

사이트맵

산부인과

산부인과

산부인과

김은택교수

전문 진료 분야
부인질환(심부자궁내막증, 자궁근종, 난소종양, 자궁탈출증), 부인종양, 부인암, 부인암 유전상담, 폐경, 로봇수술, 내시경수술(부인암 분과전문의)
김은택 교수 시간표 테이블
구분 휴진안내
오전 외래
오후 외래

학력/경력/주요활동 update 2025.05.02

    [학력사항]
    2013 고신대학교 의학과 졸업 학사
    2017 고신대학교 의학대학원 석사
    2018 산부인과 전문의
    2022 부산대학교 의학대학원 박사

    [경력사항]
    2013.03 ~ 2014.02 고신대학교복음병원 인턴
    2014.03 ~ 2018.02 고신대학교복음병원 산부인과 전공의
    2018.03 ~ 2021.04 대한민국 육군 군의관
    2021.05 ~ 2022.02 부산대학교병원 산부인과 전임의사
    2022.03 ~ 2023.02 부산대학교병원 산부인과 진료교수
    2023.03 ~ 고신대학교복음병원 산부인과 조교수
    현) 부인암 분과전문의

     

    [학회활동]
    대한산부인과학회 정회원
    대한부인종양학회 정회원
    대한부인종양학회 유전성부인암 위원회 간사
    대한부인종양학회 홍보 위원회 위원
    대한산부인과초음파학회 정회원
    대한산부인과로봇수술학회 정회원
    대한산부인과내시경학회 정회원
    대한부인종양연구회 정회원
    대한부인종양연구회 수술분과위원회 세세부위원
    대한골반신경연구회 정회원
    대한외과대사영양학회 정회원
     

논문/저서

연구 경력

저서

    *논문
    [주요 논문]

    1. Kim ET, Kim JH, Park EY, Song IH, Park HS, Park SY, Lim MC. The Efficacy and Safety of Folate Receptor α-Targeted Antibody-Drug Conjugate Therapy in Patients With High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers: A Systematic Review and Meta-Analysis. Cancer Med. 2024 Nov;13(21):e70392.
    2. Kim SI, Kim JH, Park EY, Kim ET, Choi E, Kim JW, Park SY, Lim MC. Comparison of survival outcomes and safety between early and late initiation of niraparib maintenance in newly diagnosed advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2024 Oct 23:ijgc-2024-006111.
    3. Ha HI, Yoon HJ, Song C, Kim ET, Suh D-S, Kim KH, Na YJ, Song YJ. Clinical Outcomes of Poly(ADP-Ribose) Polymerase Inhibitors as Maintenance Therapy in Patients with Ovarian Cancer in the Southeastern Region of Korea. Current Oncology. 2024; 31(11):6711-6722.
    4. Kim ET, Song YJ, Park KY, Hwang CS, Lee NK, Roh HJ, Suh DS, Kim KH. Clinical, radiological, and pathological features of mitotically active cellular fibroma of ovary: A review of cases with literature review. Taiwan J Obstet Gynecol. 2024 Sep;63(5):722-730.
    5. Kim JH#, Kim ET#, Kim SI, Park EY, Park MY, Park SY, Lim MC. Prognostic Role of CA-125 Elimination Rate Constant(KELIM) in Patients with Advanced Epithelial Ovarian Cancer Who Received PARP Inhibitors. Cancers (Basel). 2024 Jun 26;16(13):2339.
    6. Kim JH, Han KH, Parh EY, Kim ET, Kim EJ, Tan DSP, Lee JY, Park SY, Fotopoulou C, Lim MC. Efficacy of immune-checkpoint inhibitors combined with cytotoxic chemotherapy in advanced or recurrent endometrial cancer: A systematic review and meta-analysis. Gynecol Oncol. 2024 Aug;187:85-91.
    7. Kim ET, Jeong HE, Yoon HJ, Kim KH, Suh DS. Validation of multi-gene panel next-generation sequencing for the detection of BRCA mutation in formalin-fixed, paraffin-embedded epithelial ovarian cancer tissues. Taiwan J Obstet Gynecol. 2023 Jan;62(1):66-70.
    8. Ko EJ#, Kim ET#, Kim H, Lee CM, Koh SB, Eo WK, Kim H, Oh YL, Ock MS, Kim KH, Cha HJ. Effect of human endogenous retrovirus-K env gene knockout on proliferation of ovarian cancer cells. Genes Genomics. 2022 Sep;44(9):1091-1097. # : 1st co-auther
    9. Shin KH, Kim HH, Yoon HJ, Kim ET, Suh DS, Kim KH. The Discrepancy between Preoperative Tumor Markers and Imaging Outcomes in Predicting Ovarian Malignancy. Cancers (Basel). 2022 Nov 25;14(23):5821.
    10. Lee DH, Kim ET, Jo HB, Hwang SY, Lee NK, Suh DS, Kim KH. Spontaneous reduction of transvaginal small bowel evisceration after abdominal hysterectomy for cervical cancer: A case report. Medicine (Baltimore). 2022 Apr 29;101(17):e29225.
    11. Jo HB, Kim ET, Lee NK, Choi KU, Kim EJ, Shin YJ, Kim KH, Suh DS. A rare case of pure-type embryonal carcinoma in a 75-year-old woman mimicking epithelial ovarian carcinoma. Kosin Med J. 2022;37(3):249-254.
    12. Kim ET, Oh SY, Ma SY, Lee TH, Kim WG. Selective adjuvant radiation therapy for distant lymph node metastasis in patients with stage 4B epithelial ovarian cancer: a case series. Kosin Med J. 2023;38(4):293-299.
    13. Kim JH, Kim SI, Park EY, Kim ET, Kim H, Kim S, Park SY, Lim MC. Comparison of survival outcomes between olaparib and niraparib maintenance therapy in BRCA-mutated, newly diagnosed advanced ovarian cancer. Gynecol Oncol. 2024 Feb;181:33-39.
    14. Kim JH, Cho HW, Park EY, Han KH, Kim ET, Lee JK, Park SY, Armbrust R, Fotopoulou C, Lim MC. Prognostic value of CA125 kinetics, half-life, and nadir in the treatment of epithelial ovarian cancer: a systematic review and meta-analysis. Int J Gynecol Cancer. 2023 Dec 4;33(12):1913-1920.

    Google scholar profile - https://scholar.google.com/citations?view_op=list_works&hl=en&user=8B8arq8AAAAJ

     

영상